134 related articles for article (PubMed ID: 31872855)
1. Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis.
Xu H; Wei W; Y M; Dong C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31872855
[TBL] [Abstract][Full Text] [Related]
2. Trans-arterial chemoembolization combined with Jinlong capsule for advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis in a Chinese population.
Jia S; Fu Y; Tao H
Pharm Biol; 2020 Dec; 58(1):771-784. PubMed ID: 32767901
[TBL] [Abstract][Full Text] [Related]
3. The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
Liu J; Liu X; Ma J; Li K; Xu C
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31713581
[TBL] [Abstract][Full Text] [Related]
4. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.
Liu X; Li M; Wang X; Dang Z; Yu L; Wang X; Jiang Y; Yang Z
Phytomedicine; 2019 Sep; 62():152930. PubMed ID: 31128485
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis.
Sun C; Dong F; Xiao T; Gao W
Pharm Biol; 2021 Dec; 59(1):472-483. PubMed ID: 33905666
[TBL] [Abstract][Full Text] [Related]
6. Traditional Chinese biomedical preparation (Huaier Granule) for breast cancer: a PRISMA-compliant meta-analysis.
Yao X; Wu W; Qu K; Xi W
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789470
[TBL] [Abstract][Full Text] [Related]
7. Short-term effect of combined therapy with Jinlong Capsule and transcatheter arterial chemoembolization on patients with primary hepatic carcinoma and its influence on serum osteopontin expression.
Wu GL; Zhang L; Li TY; Chen J; Yu GY; Li JP
Chin J Integr Med; 2010 Apr; 16(2):109-13. PubMed ID: 20473734
[TBL] [Abstract][Full Text] [Related]
8. A Cohort Study to Examine the Use of Chinese Herbal Medicine in Combination With Conventional Therapies for Patients With Hepatocellular Carcinoma in China.
Sun L; Fahey P; Zhu X; Ng W; Chen ZP; Qiu Y; Lai H; Lin J; Lin L
Integr Cancer Ther; 2018 Sep; 17(3):902-911. PubMed ID: 29775121
[TBL] [Abstract][Full Text] [Related]
9. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
[TBL] [Abstract][Full Text] [Related]
10. Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Shu X; McCulloch M; Xiao H; Broffman M; Gao J
Integr Cancer Ther; 2005 Sep; 4(3):219-29. PubMed ID: 16113029
[TBL] [Abstract][Full Text] [Related]
11. [Effects of Jinlong Capsule on expressions of interleukin-2 and soluble interleukin-2 receptor in patients with primary liver cancer after transarterial chemoembolization therapy].
Zhang HJ; Yang JJ; Wang WX; Jiang X; Mao YJ; Yang CA; Guo JX
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):907-10. PubMed ID: 18782532
[TBL] [Abstract][Full Text] [Related]
12. Jie-du granule preparation for the treatment of advanced hepatocellular carcinoma: a retrospective cohort study of 177 patients.
Chen LY; Zhai XF; Chen Z; Zhu JF; Qian PA; Zhao HT; Ling CQ
Oncotarget; 2017 May; 8(18):30471-30476. PubMed ID: 27791987
[TBL] [Abstract][Full Text] [Related]
13. Aidi injection, a traditional Chinese biomedical preparation for gynecologic tumors: a systematic review and PRISMA-compliant meta-analysis.
Li X; Xiao C; Qu K
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33624761
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis.
Cho WC; Chen HY
Expert Opin Investig Drugs; 2009 May; 18(5):617-35. PubMed ID: 19388879
[TBL] [Abstract][Full Text] [Related]
15. [Progress in studies on anti-hepatoma effect of traditional Chinese medicine by adjusting immune function].
Yang JX; Wang XM
Zhongguo Zhong Yao Za Zhi; 2007 Feb; 32(4):281-4. PubMed ID: 17455456
[TBL] [Abstract][Full Text] [Related]
16. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis.
Liu M; Shi J; Mou T; Wang Y; Wu Z; Shen A
J Gastroenterol Hepatol; 2020 Aug; 35(8):1277-1287. PubMed ID: 32052876
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
Li L; Zhao W; Wang M; Hu J; Wang E; Zhao Y; Liu L
BMC Gastroenterol; 2018 Sep; 18(1):138. PubMed ID: 30180810
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Transarterial Chemoembolization in Combination With Kang'ai Injection on Patients With Intermediate Stage Hepatocellular Carcinoma: A Prospective Study.
Wan YM; Li YH; Xu ZY; Wu HM; Xu Y; Yang M; Wu XN
Integr Cancer Ther; 2018 Jun; 17(2):477-485. PubMed ID: 29108428
[TBL] [Abstract][Full Text] [Related]
20. Prognostic analysis of transarterial chemoembolization combined with a traditional Chinese herbal medicine formula for treatment of unresectable hepatocellular carcinoma.
Yu Y; Lang QB; Chen Z; Li B; Yu CQ; Zhu DZ; Huang XQ; Zhai XF; Ling CQ
Chin Med J (Engl); 2009 Sep; 122(17):1990-5. PubMed ID: 19781383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
